DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,993 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,991 | -99.9% | 7,500 | 0.0% | 0.53% | -5.7% |
| Q3 2022 | $1,937,000 | +1.9% | 7,500 | 0.0% | 0.56% | +6.6% |
| Q2 2022 | $1,901,000 | -14.9% | 7,500 | -1.5% | 0.53% | +2.5% |
| Q1 2022 | $2,233,000 | -8.4% | 7,614 | +2.7% | 0.52% | -2.8% |
| Q4 2021 | $2,439,000 | +7.4% | 7,414 | -0.7% | 0.53% | -2.2% |
| Q3 2021 | $2,272,000 | +13.4% | 7,464 | 0.0% | 0.54% | +15.7% |
| Q2 2021 | $2,003,000 | +16.1% | 7,464 | -2.6% | 0.47% | +8.3% |
| Q1 2021 | $1,725,000 | +1.4% | 7,664 | 0.0% | 0.43% | -8.1% |
| Q4 2020 | $1,702,000 | +3.2% | 7,664 | 0.0% | 0.47% | -7.5% |
| Q3 2020 | $1,650,000 | +17.6% | 7,664 | -3.4% | 0.51% | +9.4% |
| Q2 2020 | $1,403,000 | +27.8% | 7,932 | 0.0% | 0.47% | +3.1% |
| Q1 2020 | $1,098,000 | -11.9% | 7,932 | -2.3% | 0.45% | +18.6% |
| Q4 2019 | $1,246,000 | +6.3% | 8,118 | 0.0% | 0.38% | -0.8% |
| Q3 2019 | $1,172,000 | +0.7% | 8,118 | -0.3% | 0.38% | +1.3% |
| Q2 2019 | $1,164,000 | +8.3% | 8,143 | 0.0% | 0.38% | +5.9% |
| Q1 2019 | $1,075,000 | +20.7% | 8,143 | -5.8% | 0.36% | +7.2% |
| Q4 2018 | $891,000 | -5.1% | 8,643 | 0.0% | 0.33% | +13.6% |
| Q3 2018 | $939,000 | +4.1% | 8,643 | -5.5% | 0.29% | -2.3% |
| Q2 2018 | $902,000 | -9.2% | 9,143 | -9.9% | 0.30% | -10.4% |
| Q1 2018 | $993,000 | -32.6% | 10,143 | -36.1% | 0.34% | -30.4% |
| Q4 2017 | $1,473,000 | -20.8% | 15,868 | -26.8% | 0.48% | -22.8% |
| Q3 2017 | $1,860,000 | +0.5% | 21,680 | -1.1% | 0.63% | -3.8% |
| Q2 2017 | $1,850,000 | +1.4% | 21,923 | +2.8% | 0.65% | -5.5% |
| Q1 2017 | $1,824,000 | +228.1% | 21,322 | +198.5% | 0.69% | +142.6% |
| Q4 2016 | $556,000 | -0.7% | 7,143 | 0.0% | 0.28% | -2.4% |
| Q3 2016 | $560,000 | -22.3% | 7,143 | 0.0% | 0.29% | -25.8% |
| Q2 2016 | $721,000 | +6.3% | 7,143 | 0.0% | 0.39% | +4.0% |
| Q1 2016 | $678,000 | +1.3% | 7,143 | -0.8% | 0.38% | +5.3% |
| Q4 2015 | $669,000 | +9.0% | 7,201 | 0.0% | 0.36% | +5.9% |
| Q3 2015 | $614,000 | -11.1% | 7,201 | -10.8% | 0.34% | -2.9% |
| Q2 2015 | $691,000 | +0.7% | 8,075 | 0.0% | 0.35% | 0.0% |
| Q1 2015 | $686,000 | -0.9% | 8,075 | 0.0% | 0.35% | -2.0% |
| Q4 2014 | $692,000 | +6.1% | 8,075 | -5.8% | 0.36% | +6.3% |
| Q3 2014 | $652,000 | -3.4% | 8,575 | 0.0% | 0.33% | +0.3% |
| Q2 2014 | $675,000 | +5.0% | 8,575 | 0.0% | 0.33% | -2.1% |
| Q1 2014 | $643,000 | -6.1% | 8,575 | -3.4% | 0.34% | -11.5% |
| Q4 2013 | $685,000 | +11.4% | 8,875 | 0.0% | 0.38% | -5.4% |
| Q3 2013 | $615,000 | +15.6% | 8,875 | +5.7% | 0.41% | -1.0% |
| Q2 2013 | $532,000 | – | 8,400 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |